The new jet nebuliser family PARI LC SPRINT: a new concept for rapid drug delivery targeting different age groups

M. Hug, A. Bucholski, M. Keller, T. Selzer, M. Luber, R. G. Fischer, J. Zimmermann (Munich, Germany)

Source: Annual Congress 2006 - Evaluation of drugs for lung disease
Session: Evaluation of drugs for lung disease
Session type: Thematic Poster Session
Number: 1260
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Hug, A. Bucholski, M. Keller, T. Selzer, M. Luber, R. G. Fischer, J. Zimmermann (Munich, Germany). The new jet nebuliser family PARI LC SPRINT: a new concept for rapid drug delivery targeting different age groups. Eur Respir J 2006; 28: Suppl. 50, 1260

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Improvement of pulmonary drug delivery by eFlow™, a novel electronic inhaler making use of a vibrating membrane principle
Source: Eur Respir J 2003; 22: Suppl. 45, 472s
Year: 2003

Aerosol delivery characteristics from a new jet nebulizer in comparison with commercially available jet nebulizers
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Reduction of nebulization time can be achieved with a new jet nebulizer design
Source: Eur Respir J 2006; 28: Suppl. 50, 211s
Year: 2006

A new tool for monitoring patient adherence with aerosol therapy using an eflow nebulizer system
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009

Highly effective delivery of medication is possible in home use with improved breath-actuated nebulizer (BAN) driven by home compressor
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010

Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Validation and clinical application of a newly developed high-concentration oxygen-delivery device with a jet nebulizer function
Source: Annual Congress 2010 - COPD: management
Year: 2010


Improvement of QVAR delivery through a better sorting of drug particles: development of an innovative and easy-to-use spacer
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Investigation of Beclason efficiency in new delivery device Easi-breathe
Source: Eur Respir J 2002; 20: Suppl. 38, 499s
Year: 2002

In vitro characterisation of a novel electronic nebulizer utilising a customised single dose bfs-vial to improve handling and delivery performance
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009

A breath-actuated jet nebulizer (BAN) has dosimetric capability for a suspension formulation based on differing volume fill of medication as well as run time
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010


Reduction in nebulisation time of aqueous drug solutions by the eFlow rapid in comparison to a jet nebuliser to improve patient convenience and compliance
Source: Eur Respir J 2005; 26: Suppl. 49, 338s
Year: 2005

Reduction of treatment time for nebulized treatments using a new adaptive aerosol delivery mode
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008

Development of in-vitro models for aerosolized surfactant therapy to support customization of a novel nebulizer system based on eflow technology
Source: Annual Congress 2009 - Respiratory disorders of the newborn
Year: 2009

The mesh nebuliser: a recent technical innovation for aerosol delivery
Source: ISSN=ISSN 1810-6838, ISBN=, page=252
Year: 2006

In vitro performance of the prodose AAD® handheld - a new portable aerosol delivery system
Source: Eur Respir J 2004; 24: Suppl. 48, 581s
Year: 2004

Laboratory assessment of drug delivery of Beclomethasone/Formoterol metered dose inhaler (MDI) with a new valved holding chamber (VHC) designed specifically for 'on-the-go' use.
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Combining inhalation by a breath-actuated nebulizer (BAN) with exhalation with oscillating positive expiratory pressure device (OPEP) offers potential for simultaneous therapy
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013


Influence of nebulizer type, position and bias flow on aerosol drug delivery to a pediatric model of mechanical ventilation
Source: Annual Congress 2008 - Respiratory disorders in paediatric intensive care unit
Year: 2008


First in class, respiratory drug gas & drug vapor delivered in a revolutionary and new portable device
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015